Healthcare Resource Utilization of Ceftolozane/Tazobactam Versus Meropenem for Ventilated Nosocomial Pneumonia from the Randomized, Controlled, Double-Blind ASPECT-NP Trial
Crossref DOI link: https://doi.org/10.1007/s40121-020-00343-0
Published Online: 2020-09-30
Published Print: 2020-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lodise, Thomas
Yang, Joe
Puzniak, Laura A.
Dillon, Ryan
Kollef, Marin
Funding for this research was provided by:
Merck Sharp and Dohme
Text and Data Mining valid from 2020-09-30
Version of Record valid from 2020-09-30
Article History
Received: 13 August 2020
Accepted: 11 September 2020
First Online: 30 September 2020